Goldman Sachs’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-17,582
Closed -$248K 7052
2016
Q1
$248K Buy
17,582
+1,985
+13% +$26.6K ﹤0.01% 5424
2015
Q4
$224K Sell
15,597
-5,403
-26% -$77K ﹤0.01% 5608
2015
Q3
$283K Buy
21,000
+8,905
+74% +$128K ﹤0.01% 5666
2015
Q2
$180K Buy
12,095
+365
+3% +$5.54K ﹤0.01% 6227
2015
Q1
$178K Buy
+11,730
New +$181K ﹤0.01% 6099

Other funds holding DIAX

Goldman Sachs's DIAX Position: Q2 2016 in Review

Goldman Sachs sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q2 2016, closing a stake of 17,582 shares — an estimated $248K sold.

Goldman Sachs first reported a position in DIAX in Q1 2015 and held it in 5 quarters. The position peaked at $283K in Q3 2015. 53 funds tracked by Wall St. Rank hold DIAX as of Q2 2016.

  • Goldman Sachs reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q2 2016 after selling out during the quarter.
  • Goldman Sachs sold 17,582 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q2 2016, an estimated $248K.
  • Goldman Sachs first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q1 2015 and held it in 5 quarters.
  • Goldman Sachs's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $283K in Q3 2015.
  • 53 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q2 2016.

Based on Goldman Sachs's 13F filing for Q2 2016, filed 15 Aug 2016.